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Papillomavirus DNA replication occurs in the nucleus of infected cells and requires the viral E1 protein,
which enters the nuclei of host epithelial cells and carries out enzymatic functions required for the initiation
of viral DNA replication. In this study, we investigated the pathway and regulation of the nuclear import of the
E1 protein from bovine papillomavirus type 1 (BPV1). Using an in vitro binding assay, we determined that the
E1 protein interacted with importins 3, 4, and 5 via its nuclear localization signal (NLS) sequence. In
agreement with this result, purified E1 protein was effectively imported into the nucleus of digitonin-perme-
abilized HeLa cells after incubation with importin 3, 4, or 5 and other necessary import factors. We also
observed that in vitro binding of E1 protein to all three  importins was significantly decreased by the
introduction of pseudophosphorylation mutations in the NLS region. Consistent with the binding defect,
pseudophosphorylated E1 protein failed to enter the nucleus of digitonin-permeabilized HeLa cells in vitro.
Likewise, the pseudophosphorylation mutant showed aberrant intracellular localization in vivo and accumu-
lated primarily on the nuclear envelope in transfected HeLa cells, while the corresponding alanine replacement
mutant displayed the same cellular location pattern as wild-type E1 protein. Collectively, our data demonstrate
that BPV1 E1 protein can be transported into the nucleus by more than one importin  and suggest that E1
phosphorylation by host cell kinases plays a regulatory role in modulating E1 nucleocytoplasmic localization.
This phosphoregulation of nuclear E1 protein uptake may contribute to the coordination of viral replication
with keratinocyte proliferation and differentiation.
Papillomaviruses are the etiological agents involved in sev-
eral human cancers such as cervical cancer, anogenital cancer,
skin cancer, and cancers of the oral cavity, the larynx, and the
esophagus (68). In addition to their importance in clinical
disease, papillomaviruses have provided a valuable model sys-
tem for analyzing the mechanisms regulating eukaryotic DNA
replication. The viral E1 protein is the largest open reading
frame and is highly conserved among all papillomaviruses,
maintaining its size, amino acid composition, and location in
the viral genome with respect to other early genes. The E1
protein is expressed during the early stage of virus infection in
order to maintain the viral DNA as an episome. The multi-
functional E1 protein recognizes and binds to the viral origin
of replication in combination with the viral protein E2, recruits
host cell replication proteins to the origin, and initiates DNA
replication via its ATP-dependent helicase activity (60, 61).
Papillomavirus infection is established in the basal layer of
the epithelium, and the complex viral life cycle is coordinated
with the differentiation state of the epithelium (13, 14). There
are three distinct modes of viral DNA replication: (i) transient
amplification, which occurs immediately upon viral infection,
(ii) regulated replication for genome maintenance that occurs
in cells in the lower levels of the epidermis, and (iii) vegetative
replication for genome amplification, which occurs in termi-
nally differentiated cells in the epidermis. In the latter cells,
control of copy number appears to be lost, and viral DNA is
amplified up to very high copy numbers (13, 15, 50). To meet
these replication requirements, the E1 protein is regulated not
only at the expression level (44) but also by posttranslational
modifications such as sumoylation (48, 49), ubiquitination (34,
38), and phosphorylation. Bovine papillomavirus type 1 (BPV1)
E1 protein is phosphorylated at multiple sites and by different
kinases, including serines 48 and 584 by CKII (29, 36, 37), threo-
nine 102 by p34cdc2 (9, 30), and serine 109 by protein kinase C
(PKC) (64). Mutational analysis indicates that changes in these
residues can affect viral replication, but in most cases, mechanistic
details are lacking.
One possibility for the control of E1 replicative activity
would be to regulate E1 levels in the nucleus. Although the
molecular events involved in the nuclear accumulation of
BPV1 E1 remain mostly uncharacterized, a nuclear localiza-
tion signal (NLS) has been mapped to amino acids 84 to 108
(30). There are two clusters of three or four consecutive basic
residues within this region, and both clusters contribute to NLS
function. This NLS is both necessary and sufficient to mediate
nuclear uptake of E1 or reporter proteins, indicating that no
other region of E1 is mandatory for nuclear import (28, 30).
Phosphorylation is a common mechanism controlling the nu-
clear transport of many proteins (20), and two of the known E1
phosphorylated residues, threonine 102 and serine 109, are
located at the NLS, suggesting the possible regulation of nu-
clear uptake via E1 phosphorylation. While a mutation of
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threonine 102 to isoleucine was previously shown to have no
observable effect on either the nuclear localization of E1 or
viral DNA replication (30), a thorough examination of the
contribution of phosphorylation of these residues to nuclear
localization has not been performed.
Classic NLS-dependent nuclear import is a two-step process.
The first step is the assembly of an importin / complex with
the NLS of the cargo protein followed by binding to the nu-
clear pore complex. The second step is translocation across the
membrane, where importin  is released from the complex
after interaction with Ran-GTP, resulting in the dissociation of
the cargo from the transport proteins (16, 33). There are six
human importin  proteins (1, 3, 4, 5, 6, and 7) that
fall into three subfamilies, P (1), Q (3 and 4), and S (5,
6, and 7) (19). In this study, we investigated the interaction
of BPV1 E1 with the various importin  proteins and identified
three importins that bound E1 and supported nuclear import
in vitro. Pseudophosphorylation in the NLS region abrogated
this in vitro E1-importin  interaction, prevented nuclear up-
take in an in vitro import assay, and caused the mislocalization
of E1 in vivo. Our results are consistent with the cytoplasmic
phosphorylation of E1 being a negative regulator of nuclear
entry.
MATERIALS AND METHODS
Plasmids and mutagenesis. Plasmids pcDNA3.1-HA-E1, pRSET-E1, peGFP-
E1, pGEX5X1-E11–311, and pGEX-T-E2 and the pseudophosphorylation mu-
tants (CDK, CKII, ALL, and 1098) were all described in previous studies (48, 49,
51, 62). Targeted mutagenesis to inactivate the E1 NLS or to introduce amino
acid replacements (alanines or aspartic acids) at E1 residues 102 and 109 was
performed using the QuikChange XL or Multi site-directed mutagenesis kit
(Stratagene, La Jolla, CA), and the sequence of each construct was confirmed by
sequencing. Importin  clones (pQE70-1, pQE60-3, pQE60-4, pQE60-5,
and pQE70-7) were provided by Matthias Kohler (26), importin 1 clones
(pGEX6p-1/Kap1) were provided by Yuh Min Chook (7), pCR3-HPV11-E1
was provided by Jacques Archambault (57), pGEX-2T-Ran was provided by Ian
Macara (45), His-Com1 was provided by Guoquan Zhang (66), pGST-NLS was
provided by Mark Hannink (52), and pREV1-4(NES3)GFP was provided by
Beric Henderson (18).
Expression and purification of protein. For the His fusion proteins (pQE70-
1, pQE60-3, pQE60-4, pQE60-5, pQE70-7, and His-Com1), expression
was performed in cultures of Escherichia coli M15[pREP4] cells (QIAGEN,
Valencia, CA) grown to an optical density at 600 nm of 0.9 and induced with 0.2
mM IPTG (isopropyl--D-thiogalactopyranoside) for 4 h at 25°C. Phenylmethyl-
sulfonyl fluoride (PMSF) (5 mM) was added immediately before the culture was
chilled on ice. After collection by centrifugation, the bacterial pellet was resus-
pended in cold lysate buffer (500 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8
mM KH2PO4, and 5 mM imidazole, pH 7.3) supplemented with a 1/100 volume
of protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and 1 mg/ml
lysozyme, and the suspension was sonicated. After sonication, the lysate was
cleared by centrifugation at 15,000  g for 15 min at 4°C, and the supernatant
was loaded onto Ni-nitrilotriacetic acid (NTA) agarose (QIAGEN, Valencia,
CA). The beads were washed four times with 10 bead volumes of wash buffer
(500 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4) consec-
utively containing 5 mM, 20 mM, 40 mM, or 50 mM imidazole. Elution from the
column was performed four times with 1 bead volume of elution buffer (500 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, and 500 mM imid-
azole). The eluted fractions were pooled and dialyzed overnight against 1
Tris-buffered saline (TBS) (50 mM Tris-HCl [pH 7.4], 150 mM NaCl) supple-
mented with 5% glycerol. After sucrose addition to a final concentration of 250
mM, His-tagged proteins were stored at 80°C. The purified the protein con-
centrations were determined by a Bradford assay (6).
For the glutathione S-transferase (GST) fusion proteins (pGEX5X1-E11–311,
pGEX-T-E2, pGST-NLS, pGEX-2T-Ran, pGEX6p-1/1, and pGEX-mCry2),
expression was performed in cultures of E. coli Rossetta(DE3) Single cells
(Novagen, San Diego, CA) grown to an optical density at 600 nm of 0.9 and then
induced with 0.2 mM IPTG at 25°C for 4 h. After centrifugation, the bacterial
pellet was resuspended and sonicated in cold 1 phosphate-buffered saline
(PBS) (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4, pH
7.3) containing 5 mM dithiothreitol, 1 mg/ml lysozyme, and a 1/100 volume of
protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Following sonication,
the lysate was cleared by centrifugation at 15,000  g for 15 min at 4°C, and the
supernatant was loaded onto glutathione-Sepharose 4B beads (Amersham,
Piscataway, NJ) for 3 h at 4°C. The beads were washed with 10 bead volumes of
1 PBS containing 0.2 mM PMSF, 10 bead volumes of 1 PBS containing 750
mM NaCl and 0.2 mM PMSF, 10 bead volumes of 1 PBS containing 0.2 mM
PMSF, and another 10 bead volumes of 1 PBS. Each GST fusion protein was
eluted three times with 1 bead volume of 100 mM Tris-HCl (pH 8.0), 120 mM
NaCl, and 20 mM reduced glutathione, and the three eluates were pooled. The
eluted proteins were dialyzed overnight against 1 TBS supplement with 10%
glycerol, the protein concentrations were determined as described above, and the
samples were stored at 80°C.
In vitro protein translation and importin binding assay. For the importin
binding assay, 35S-labeled protein was produced in coupled in vitro transcription
and translation reactions. Briefly, 2 g of E1-encoding plasmid DNA was mixed
with 32 Ci of Redivue L-[35S]methionine (Amersham, Piscataway, NJ) and 25
l of the TNT T7 Quick Coupled transcription/translation system (Promega,
Madison, WI) in a final volume of 31 l. After incubation at 30°C for 90 min, the
samples were frozen at 80°C or used directly in binding assays.
For the importin  binding assay using affinity-purified His-tagged fusion
proteins (His-Com1 or the five  importins), 0.5, 1, or 2 g of the purified
His-tagged proteins was incubated with 40 l of Ni-NTA agarose (QIAGEN,
Valencia, CA) and 3 l of 35S-labeled in vitro-translated E1 in a total volume of
500 l containing 1 PBS, 5 mM MgCl2, 0.5% Triton X-100, and 20 mM
imidazole. After incubation at 4°C for 3 h, the beads were washed four times with
1 PBS supplemented with 5 mM MgCl2, 0.5% Triton X-100, and 20 mM
imidazole. The bound in vitro-translated E1 proteins were eluted with 15 l of
4 sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE)
sample buffer (100 mM Tris-HCl [pH 6.8], 20% glycerol, 8% SDS, 0.02% bro-
mophenol, and 4% 2-mercaptoethanol), resolved on 10% SDS-PAGE gels, and
analyzed by phosphordensitometry. As a positive control for importin 7, bind-
ing was tested using GST-mCry2 as the substrate.
For importin binding assays supplemented with GST-importin 1, E1/importin
/importin 1 complexes were captured by glutathione affinity chromatography.
Each binding reaction mixture contained 2 g of the appropriate GST fusion
protein (GST-importin 1 or GST), one of the His-tagged  importins (0.5, 1, or
2 g), and 3 l of 35S-labeled in vitro-translated E1 protein (expressed from
pRSET). Reaction mixtures were incubated with 40 l of glutathione-Sepharose
4B (Amersham, Piscataway, NJ) in a total volume of 500 l containing 1 TBS
supplemented with 0.05% Tween 20, 5 mM MgCl2, and 0.5% bovine serum
albumin. After incubation at 4°C for 3 h, the beads were washed three times with
10 bead volumes of loading buffer and then washed one time with 10 bead
volumes of the loading buffer without 0.5% bovine serum albumin. The bound in
vitro-translated E1 proteins were eluted with 15 l of 4 SDS-PAGE sample
buffer. In vitro binding reactions for BPV1 E1 and E2 were performed as
previously described (62).
Cell culture, transfection, and nuclear import assay. HeLa cells were grown in
10% fetal bovine serum-supplemented Dulbecco’s modified eagle’s medium at
37°C and 5% CO2 in a humidified incubator. Transfections were performed using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s
instructions. After transfection, E1 cellular localization was visualized by fluo-
rescence microscopy as previously described (48). Nuclear import assays were
performed as reported previously (1, 63). For the nuclear import assay, a 10 M
solution of the E1 protein was incubated with 50 M of Alexa-555 maleimide
(Molecular Probes) for 2 h at room temperature in 1 TBS. Reaction mixtures
were quenched by the addition of 2-mercaptoethanol to a final concentration of
18 mM, and the fluorescently labeled E1 proteins were purified with a 30K
Nanosep column (Pall, East Hills, NY) to remove free dye. Labeling efficiency
for equal microgram amounts of each purified protein sample was assessed
spectrophotometrically at an absorbance of 555 nm, and there was less than 10%
difference between wild-type (WT) E1 and the various mutant E1 proteins. HeLa
cells grown on coverslips in a 12-well plate were permeabilized with 1 ml of 40
g/ml digitonin on ice for 2 min and incubated at room temperature for 10 min
in the dark with 40 l of an import reaction mixture containing 0.5 M Alexa-
555-labeled BPV1 E1 protein, 0.5 M importin , 0.5 M importin 1, 1 mM
GTP, 2 M Ran, 1 M NTF2 (kindly provided by Weidong Yang) (63), and
1.5% polyvinylpyrrolidone in 1 transport buffer [20 mM HEPES, 110 mM KAc,
2 mM Mg(Ac)2, 1 mM EGTA, and 5 mM NaAc]. After washing one time with
1 ml of 1 transport buffer supplemented with 1.5% polyvinylpyrrolidone, E1
cellular localization was visualized by fluorescence microscopy.
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Coimmunoprecipitation. HeLa cells (1  106 cells) were transfected with 10
g of peGFP or peGFP-BPV1E1. After 24 h, cells were harvested and lysed with
800 l of lysis buffer (0.3 M NaCl, 1% Triton X-100, 50 mM HEPES buffer, pH
8.0) containing protease inhibitor cocktail (Pierce, Rockford, IL) and phenyl-
methylsulfonyl fluoride. For each immunoprecipitation, 1 g of each anti-
importin  (Abcam, Cambridge, MA) and 20 l of protein G (Santa Cruz, CA)
were incubated with the cell lysate for 3 h at 4°C on a circular rotor. The beads
were then pelleted, washed with 1 PBS, and eluted with SDS-sample buffer.
Eluted polypeptides were resolved on a 10% SDS-polyacrylamide gel and ana-
lyzed by immunoblot analysis with anti-green fluorescent protein (GFP) (Santa
Cruz, CA) and individual anti-importin antibodies.
Loading of Ran with GTP. Purified Ran (33 g; cleaved from GST-Ran) was
incubated with guanine nucleotide exchange buffer (100 mM Tris-HCl [pH 7.5],
250 mM NaCl, 2 mM dithiothreitol, 10 mM EDTA, and 5 mM GTP) in a total
volume of 66 l on ice overnight. After loading, the reaction was stopped by
adding MgCl2 to a final concentration of 20 mM. Ran-GTP was purified with a
BioGel P-6 Micro Biospin chromatography column (Bio-Rad, Hercules, CA)
according to the user’s manual.
RESULTS
BPV1 E1 protein binds to importins 3, 4, and 5 in vitro
via its nuclear localization signal but not to importins 1 and
7. BPV1 E1 protein contains a well-defined NLS (28, 30), and
such elements typically interact with importin . Six importin 
proteins have been described in humans, but no information
about the relationship between different importin  proteins
and the nuclear import of BPV1 E1 has been reported. To
identify relevant importin  proteins, we tested complex for-
mation between in vitro-translated E1 (pcDNA3.1-HA-E1)
and His-tagged importin proteins using a pull-down assay (Fig.
1). The in vitro transcription/translation reactions produced
full-length E1 and a variable amount of a 55-kDa form. As the
precise sequences present in the shorter form are unknown,
our conclusions are based entirely on results with full-length
E1. His-tagged Com1, a bacterial protein (66), was used as the
negative control for nonspecific binding. Full-length wild-type
E1 bound importins 3, 4, and 5 in a dose-dependent fash-
ion but had minimal association with importin 1 or 7 (Fig.
1B to D). Importin 6 was not examined in our studies, as its
expression is restricted to the testis (24). The percentage of
input E1 bound at the highest quantity of importin tested was
approximately 15 to 20% for 3 to 5 and was less than 1% for
1 and 7 (Fig. 1D). The NLS dependence of these interac-
tions was verified using an NLS-minus mutant (Fig. 1A) con-
structed based on previous data showing that a mutation of
both clusters of basic amino acids was necessary and sufficient
to eliminate E1 nuclear import (28, 30). A third cluster of basic
residues (amino acids 112 to 114) adjacent to the NLS was also
mutated to ensure that it would have no possible contribution
to the E1-importin interaction. The NLS mutant had signifi-
cantly reduced binding to importins 3, 4, and 5 (Fig. 1B),
confirming that the observed E1-importin interactions were
mediated via this NLS motif. NLS-dependent E1 binding to
these same importins was also observed using a yeast two-
hybrid system (data not shown). The low-level binding of E1 to
importins 1 and 7 was not affected by the NLS mutations
and likely reflects nonspecific interactions under these in vitro
conditions.
In addition to BPV1 E1, we also tested importin  binding
by human papillomavirus type 11 (HPV11) E1 (Fig. 1E), which
has a bipartite cluster of basic amino acids comparable to the
NLS sequence of BPV1 E1. As for BPV1 E1, HPV11 E1
interacted effectively with importins 3 to 5 but not 7. Sur-
prisingly, HPV11 E1 also bound importin 1 but to a slightly
lower extent than the other importins. The significance of the
importin 1 binding by HPV11 E1 is unknown and has not
been investigated further. Since importin 7 bound neither
BPV nor HPV E1, its functionality was assessed by testing its
interaction with a known substrate, mCry2 (Fig. 1F). Importin
7 bound GST-mCry2, but not GST, indicating that the puri-
fied protein was functional yet unable to bind E1 proteins.
Lastly, the ability of BPV E1 to bind importins in vivo was
tested in HeLa cells. When expressed via transfection, E1 was
coimmunoprecipitated with importin 4 (Fig. 1G) and importin
3 (data not shown), confirming the intracellular interaction be-
tween E1 and these importins.
BPV1 E1 is transported into the nucleus by importins 3,
4, and 5 but not by importins 1 and 7 in an in vitro
nuclear import assay. Having established that BPV1 E1 pro-
tein binds to importins 3, 4, and 5 in vitro, we examined the
functionality of this interaction using an in vitro digitonin-
permeabilized cell nuclear import assay. This system requires
the reconstitution of the permeabilized cells with exogenous
transport factors, including  importins, in order to restore
nuclear uptake. The transport substrates GST-E11–311-WT,
GST-E11–311-NLS
, and GST-NLS (a positive control with the
simian virus 40 T-antigen NLS) were expressed in E. coli cells,
and the affinity-purified fusion proteins are shown in Fig. 2A.
The truncated GST-E11–311 form of E1 was used in this assay,
since this fragment is more easily expressed and purified than
full-length E1, it contains the NLS sequence for nuclear trans-
port, it is conformationally intact, as indicated by its function-
ality for binding origin DNA and the E2 protein (27), and the
presence of the GST moiety results in a fusion protein similar
in size to that of full-length E1. All the purified fusion proteins
were labeled with Alexa-555 for monitoring by fluorescence
microscopy.
In the presence of importin , the control GST-NLS protein
was efficiently imported into the nucleus (Fig. 2B). In contrast,
nuclear fluorescence was not observed when importin  was
omitted from the reconstitution mixture, confirming the spec-
ificity of this system. Similarly, GST-E11–311-WT protein was
not localized to the nucleus in the absence of an importin ,
but a nuclear fluorescence signal was readily detected in the
presence of importin 3, 4, or 5 (Fig. 2C). The GST-E11–311-
NLS protein, which was unable to bind any of the importins,
was not imported. Furthermore, the nuclear signal was greatly
reduced for GST-E11–311-WT when assayed with either importin
1 or 7, both of which exhibited only low levels of nonspecific
binding to E1. Thus, the binding and nuclear uptake results are
in complete concordance and indicate that the complexes
formed between E1 and importins 3, 4, and 5 are fully
functional for NLS-dependent nuclear import.
Pseudophosphorylation inhibits the interaction between
BPV1 E1 and importin . The presence of two known phos-
phorylated residues, threonine 102 and serine 109, in the vi-
cinity of the BPV1 E1 NLS raised the possibility that phos-
phorylation might regulate the interaction between E1 and
importin . To address this possibility, a double pseudophos-
phorylation mutant (E1-MD) was constructed by converting
both threonine 102 and serine 109 to aspartic acid. A second
double-replacement mutant containing an uncharged alanine
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at positions 102 and 109 (E1-MA) was also constructed (Fig.
1A). In vitro-translated E1-WT, E1-MA, and E1-MD proteins
were assessed for importin  interactions with a variation of
the pull-down binding assay described in the legend of Fig. 1.
It is known that  importins are partially autoinhibited for
substrate binding and that this autoinhibition is relieved by
conformational changes that occur upon importin 1 binding
(23). Endogenous importin 1 present in the reticulocyte ly-
sate used for in vitro translation of the E1 proteins was pre-
sumably sufficient to allow the effective binding seen in Fig. 1,
but to ensure a completely adequate supply of 1 in this ex-
periment, we supplemented the E1 and importin  reaction
mixtures with purified GST-importin 1 and captured the com-
plexes on glutathione beads. No significant differences were
observed in binding assays performed in the absence or pres-
ence of exogenous importin 1.
Under the above-described conditions, E1-WT exhibited
dose-dependent binding to importins 3, 4, and 5, similar to
what was observed in the absence of exogenous importin 
(Fig. 3A). The binding of the E1-MA mutant protein to the
FIG. 1. Papillomavirus E1 proteins bind  importins in vitro. (A) The sequence of WT BPV1 E1 protein in the region of the NLS is shown,
with the clusters of basic residues underlined. The amino acid changes present in three mutant E1 proteins (NLS; a double pseudophosphory-
lation mutant, MD; and the uncharged double-alanine mutant MA) constructed for this study are indicated below the WT E1 sequence.
(B) Autoradiograph of the in vitro-translated HA-E1-WT and HA-E1-NLS proteins bound to His-Com1 (2.0 g) or increasing amounts (0.5, 1.0,
and 2.0 g) of different importin  proteins (indicated by the hollow triangles). The input panel shows a sample of the in vitro-translated E1
proteins used for the binding assay. (C) Immunoblot of the His-importin  fusion proteins used in the pull-down assay shown in B. His-importins
were detected with an anti-His antibody. (D) Quantification of the full-length WT E1 product (75 kDa) bound to His-Com1 and the different
importin  proteins by phosphordensitometry. The amount of bound NLS E1 was subtracted from the amount of bound WT E1 for Com1 and
each of the five  importins tested, and the difference is presented as the percentage of the input WT E1 protein. Error bars represent standard
errors obtained in two or three experiments. (E) Autoradiograph of the in vitro-translated HPV11 E1 bound to His-Com1 (2.0 g) or increasing
amounts (0.5, 1.0, and 2.0 g) of different importin  proteins (upper panel). The assay was performed as described above for BPV1 E1. The lower
panel shows the immunoblot of the importins as in C. Numbers to the left of the blots and autoradiographs in B, C, and E show the positions of
molecular mass markers (in kilodaltons). (F) Immunoblot of GST-mCry2 bound to 1.0 g of importin 7. Equal amounts of GST or GST-mCry2
were incubated with 7, the complexes were collected on Ni-NTA agarose, and the bound material was detected with anti-GST. (G) Coimmu-
noprecipitation of E1 with  importin. Extracts from cells expressing either eGFP or eGFP-E1 were immunoprecipitated with anti-importin 4
and then immunoblotted with anti-GFP or anti-importin 4 as indicated.
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importins was comparable to that of E1-WT (Fig. 3A and C),
indicating that neither threonine 102 nor serine 109 was critical
for E1-importin interactions. In contrast, the pseudophosphor-
ylation mutant E1-MD showed greatly reduced interactions
with all three  importins. Quantitation by phosphordensitom-
etry indicated that the E1-MD mutant had only 20 to 25% of
wild-type binding activity. It is unlikely that the reduced inter-
action of the E1-MD protein with the  importins was due to
a global conformational defect, since E1-MD bound E2 pro-
tein just as effectively as E1-WT and E1-MA (Fig. 3A and C).
None of the three E1 proteins showed any significant binding
to control GST protein (Fig. 3A). Overall, these results impli-
cate phosphorylation as a negative regulator of E1-importin 
interactions.
Unlike importins 3, 4, and 5, importins 1 and 7 did
not interact effectively with unmodified BPV1 E1 protein. Con-
sequently, it is possible that importins 1 and 7 might require
an NLS modification, such as phosphorylation, to facilitate
their interaction with E1. However, the E1-MD pseudophos-
phorylation mutant showed no increased binding to either of
these importins compared to E1-WT or E1-MA (Fig. 3D).
While a positive regulatory role for posttranslational modifi-
cations at other amino acids cannot be ruled out from this
experiment, phosphorylation at residues 102 and 109 is un-
likely to be involved in targeting importin 1 or 7 for the E1
interaction.
In the nucleus, importin 1 is released from the cargo/
importin complex after an interaction with Ran-GTP (16, 33).
As a further measure of the authenticity of our E1/ impor-
tin/ importin complexes, we sought to test if Ran-GTP had
the same releasing activity in the in vitro binding assay. As
shown for importin 5 in Fig. 3E, the interaction between
importin 1 and the importin 5/E1-WT or E1-MA complexes
was reduced in the presence of increasing amounts of Ran-
GTP, as expected. However, Ran-GTP did not affect the low
level of binding seen with the E1-MD complex, suggesting that
this binding does not reflect an authentically assembled trans-
port complex. Similar results were obtained with 3 and 4
(data not shown).
Pseudophosphorylation regulates E1 nuclear import both in
vitro and in vivo. Based on our results showing that pseu-
dophosphorylation inhibited the interaction between BPV1 E1
and importin , we attempted to determine if this inhibition
regulates E1 nuclear localization. For in vitro nuclear import
studies, the MA and MD mutations were constructed into the
pGEX5X1-E11–311 backbone for expression in E. coli cells
and subsequent purification. Purified recombinant proteins
GST-E11–311-WT, GST-E11–311-MA, and GST-E11–311-MD
are shown in Fig. 4B. When added to the permeabilized cells,
the GST-E11–311-MA protein accumulated in the nucleus as
effectively as wild-type GST-E11–311 protein when incubated
with importin 3, 4, or 5 (Fig. 4A). These results confirm
that neither threonine 102 nor serine 109 is intrinsically critical
for nuclear transport of the E1 protein. In contrast to the
GST-E11–311-MA results, none of these three importin  pro-
teins could transport GST-E11–311-MD into the nucleus, con-
sistent with the conclusion that the reduced importin binding
due to the pseudophosphorylation of E1 was sufficient to pre-
vent the nuclear localization of E1.
To examine the pseudophosphorylation phenotype in vivo,
we developed enhanced GFP (eGFP)-E1 fusions for the over-
expression of wild-type, MA, and MD E1 proteins in HeLa
cells. The pREV1-4(NES3)GFP vector served as a positive
control expressing a predominantly nuclear protein. After
transfection, the eGFP-E1-WT protein showed a cellular lo-
calization pattern consisting of a diffuse nuclear signal and
FIG. 2. The BPV1 E1 protein is imported into the nuclei of permeabilized cells by importins 3, 4, and 5 but not by importins 1 and 7.
(A) Coomassie blue staining of 0.5 g of the purified GST-NLS, GST-E11–311-WT, and GST-E11–311-NLS
 proteins used for the in vitro uptake
assay. The positions of molecular mass markers (in kilodaltons) are indicated on the left side of each panel. (B) Nuclear import assay of the
fluorescence-labeled GST-NLS fusion protein (positive control) tested in the absence or presence of different importin  proteins as indicated. The
assay was performed as described in Materials and Methods, and the labeled GST-NLS protein was detected by fluorescence microscopy.
(C) Nuclear import assay as in B with fluorescence-labeled GST-E11–311-WT and GST-E11–311-NLS
.
VOL. 81, 2007 NUCLEAR IMPORT REGULATION OF BPV1 E1 PROTEIN 2903
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
considerable cytoplasmic fluorescence (Fig. 4C). The degree of
cytoplasmic signal was somewhat unexpected but appears to be
due to a high level of expression from this vector and nuclear
export signal-dependent active nuclear export of BPV1 E1
protein (our unpublished data). Nonetheless, the MA mutant
was indistinguishable from wild-type E1 in its localization,
again confirming that there is no intrinsic requirement for
threonine and serine at positions 102 and 109, respectively, in
order for E1 to be transported into the nucleus. However, the
MD mutant gave a completely different pattern, with accumu-
lation on the nuclear envelope of the transfected cells (Fig.
4C), indicating that the pseudophosphorylation of these two
residues disrupted the normal nuclear localization of E1. The
mechanistic basis for this aberrant localization pattern is un-
clear, but perhaps the Ran-GTP-unresponsive importin 1/
importin /E1-MD complex seen in Fig. 3E also forms in vivo
and becomes dsyfunctionally associated with the nuclear pores.
Alternatively, the failure to observe nuclear envelope accumu-
lation of E1 in vitro may simply reflect a limitation in the in
vitro assay system. The in vitro system was reconstituted with
the minimal components required for import and likely lacks
additional factors that contribute to overall transport regula-
tion in vivo. For example, our reconstituted import system does
not support nuclear export, and we have recently determined
that BPV1 E1 contains a Crm1-dependent nuclear export sig-
nal sequence (G. Rosas-Acosta et al., unpublished data). Re-
gardless of the mechanism involved, these results are consis-
tent with authentic phosphorylation being a negative regulator
of E1 nuclear import. Whether or not the aberrant distribution
of the MD mutant E1 protein would be ameliorated in the
presence of other viral proteins, such as E2, has not been
tested.
FIG. 3. Pseudophosphorylation of the BPV1 E1 protein at T102 and S109 reduces its binding activity to importin  proteins in vitro.
(A) Autoradiograph of the in vitro-translated His-E1-WT, His-E1-MA, and His-E1-MD proteins (expressed from pRSET) bound to  importins
in the presence of GST (upper right panel) or GST-importin 1 (3, 4, and 5 panels) or to GST-E2 alone (BPV1-E2 panel) as described in
Materials and Methods. Hollow triangles indicate increasing amounts of  importins or BPV1 E2 used in the binding reaction mixtures (0.5, 1.0,
and 2.0 g). The input panel (upper left) shows a sample of the in vitro-translated WT and mutant E1 proteins. The position of a 75-kDa molecular
mass marker is indicated to the left. (B) Immunoblots of importins  and 1 used in pull-down assay shown in A. Proteins were detected with
anti-His ( importins) or anti-GST ( importin) antibody. (C) Phosphordensitometric quantification of the full-length E1 product (75 kDa) bound
to  importins in the presence of importin 1 or bound to BPV1 E2 protein. Data shown in the graph are derived from binding reactions shown
in A using 2.0 g of wild-type or mutant E1 proteins. The binding activities of the E1-MA and E1-MD mutants are relative to that of the WT BPV1
E1 protein, which was assigned as 100%. Error bars represent standard errors obtained in two or three experiments. (D) The upper panel is an
autoradiograph of in vitro-translated WT or mutant E1 protein bound to complexes of 1/GST-1, 7/GST-1, or GST alone. The input lanes
show portions of the original in vitro translation reaction for the WT, MA, and MD E1 proteins as indicated. The lower panel is an immunoblot
of  importins used in the pull-down assay shown in the upper panel. The importins were detected with anti-His antibody. (E) The E1 binding assay
was performed with WT and mutant E1 proteins as in A except with the inclusion of 0.5, 1.0, or 2.0 g of Ran-GTP in the reaction mixture, as
indicated by the hollow triangles. The lane marked I shows the input WT E1 protein.
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Effect of other possible modifications on BPV1 E1 nuclear
import. Besides threonine 102 and serine 109 located at the
NLS sequence, the BPV1 E1 protein is phosphorylated or
predicted to be phosphorylated at several additional amino
acid residues by the action of different host kinases (61). There
are two reported CKII sites, serines 48 and 584 (29, 36, 37),
and two putative CDK sites, threonine 126 and serine 283, in
addition to the known CDK site at threonine 102. To test if
phosphorylation at these other four sites might regulate E1
nuclear import, we examined the importin  binding capacities
of three additional sets of pseudophosphorylation mutants:
CKII (S48D/S584D), CDK (T102D/T126D/S283D), and ALL
(S48D/T102D/T126D/S283D/S584D) (51). As shown in Fig. 5,
the importin 5 binding activities of the pseudophosphoryla-
tion mutants CKII, CDK, and ALL were 107%, 76%, and 16%
of those of wild-type E1, respectively. From these results, we
conclude that phosphorylation at the CKII sites is unlikely to
contribute to the regulation of E1 nuclear uptake. The modest
decrease in binding activity seen with the CDK mutant, which
includes threonine 102, suggested that phosphorylation at the
CDK sites is relatively unimportant for importin binding and
that serine 109 phosphorylation might be the major contribu-
tor to E1-importin  interactions. To assess this possibility, a
single pseudophosphorylation mutant at serine 109 (desig-
nated 1098) was tested. The 1098 mutation reduced importin 
binding to 36% of wild-type levels (Fig. 5C) compared to the
double pseudophosphorylation mutant E1-MD, which reduced
the binding activity to 25% for importin 5 (Fig. 3C). We
conclude from these combined results that phosphorylation at
threonine 102 and other CDK sites would have only a minor
effect on importin binding, whereas serine 109 phosphorylation
would significantly reduce importin binding and the subse-
quent transport of E1 into the nucleus. The somewhat more
severe binding defect observed for the ALL mutant (16% of
wild-type binding versus 36% for 1098) may indicate modest
cumulative contributions of the other pseudophosphorylations
combined with the S109D effect. Alternatively, the extensive
mutational burden in the ALL mutant protein may simply
result in structural perturbations that further reduce the ability
of E1 to bind importins rather than a specific contribution
through the introduced charged residues.
DISCUSSION
The location and sequence features of the BPV1 E1 NLS are
well defined (28, 30, 56); however, the molecular events in-
volved in the nuclear transport of E1 remain mostly undefined.
For the first time, we demonstrate that BPV1 E1 interacts with
FIG. 4. Pseudophosphorylation of BPV1 E1 at T102 and S109 affects BPV1 E1 protein nuclear import. (A) Nuclear uptake of GST-E11–311-
WT, GST-E11–311-MA, and GST-E11–311-MD in permeabilized HeLa cells supplemented with importins 3, 4, and 5 as indicated. The assay was
performed as described in the legend of Fig. 2, and the localization of the E1 protein was detected by fluorescence microscopy. (B) Coomassie blue
staining of 0.5 g of GST-E11–311-WT, GST-E11–311-MA, and GST-E11–311-MD proteins used in the in vitro import assay, with the molecular mass
markers (in kilodaltons) indicated on the left. (C) HeLa cells were transfected with peGFP-E1-WT, peGFP-E1-MA, peGFP-E1-MD, and
pREV1-4(NES3)GFP (positive control). The cellular localization of the E1 protein was detected 24 h after transfection by fluorescence microscopy
for the eGFP signal.
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multiple  importins and that this interaction is functional for
in vitro nuclear import, suggesting that the classical importin
/ pathway serves to transport E1 in vivo as well (Fig. 1 and
2). Utilization of the / transport pathway by E1 is consistent
with previous observations that several other papillomavirus
proteins, including L1 (HPV11, HPV16, and HPV45), L2
(HPV16), and E6 (HPV16), also enter the nucleus via the
importin 1/1 pathway (11, 32, 39, 41–43). In addition, we
found that HPV11 and HPV16 E2 proteins, which both con-
tain a well-characterized NLS (4, 55, 67), also displayed in vitro
binding to importins 3 and 5 (unpublished data). Thus, it
appears likely that papillomaviruses have evolved to utilize the
classical NLS-dependent / transport pathway as a general
mechanism for nuclear entry of the larger viral proteins. How-
ever, it is also clear that some papillomavirus proteins can
enter the nucleus via importin -independent pathways, such
as direct binding to  importins for HPV16 L2 (11) or E6 (32),
or a nonclassical Ran-dependent pathway for HPV16 E7 (3).
BPV1 E1 was unable to be imported into the nuclei of perme-
abilized cells by  importins alone (unpublished data), sup-
porting an obligate role for  importins in E1 nuclear trans-
port, but further in vivo study will be required to fully eliminate
other possible entry mechanisms.
The importin  family is encoded by six genes in humans,
namely, importin 1 (Rch1 or KPNA2) (10, 59), importin 3
(Qip1 or KPNA4) (24, 53), importin 4 (hSRP1 or KPNA3)
(24, 40), importin 5 (hDRP1 or KPNA5) (8), importin 6
(24), and importin 7 (26). These six importin  proteins differ
in their primary structures, substrate-specific import efficien-
cies, and tissue/cell-specific expression patterns (24, 26, 40) yet
can be grouped into three subfamilies based on sequence sim-
ilarities: -P (importin 1), -Q (importins 3 and 4), and
-S (importins 5 to 7) (19). Expression of importin 6 is
restricted to the testis (24), while the other five  importins are
widely expressed in most tissues and cell types, including ke-
ratinocytes (21, 25, 58; our unpublished observations). Our
results indicate that BPV1 E1 bound to members of both the
-Q (3 and 4) and -S (5) families but not to members of
the -P family. The significance of this binding pattern is not
yet known but may reflect the biology of importin  expression
in the epithelium. Several recent studies have begun to exam-
ine the relationship between importin expression and cell pro-
liferation or differentiation. Levels of importin  proteins ap-
pear to be coordinated with cellular proliferation, and the
down-regulation of importin 3, 5, or 7 inhibits HeLa cell
proliferation, while the down-regulation of importins 1 and
4 had only a minor or no effect (47). In two different cell
culture models of differentiation, levels of importins 1, 4,
and 7 were strongly decreased during differentiation, while 3
and 5 levels were stable or upregulated (25). These observa-
tions have not yet been extended to stratified keratinocytes but
suggest that intracellular levels of different  importins could
vary widely across the epithelial layers. The effective binding
and transport of E1 protein by multiple  importins would
provide efficient nuclear entry irrespective of the differentia-
tion stage of the cell. Additionally, there could be regulatory
implications for viral genome replication if differentiation-de-
pendent changes in importin  levels influence the overall
abundance of nuclear E1 protein.
Many proteins contain a phosphorylation site within or ad-
jacent to their NLS sequence that contributes to the regulation
of nuclear localization. For example, the phosphorylation of
FIG. 5. Examination of other possible posttranslational modification sites of BPV1 E1 for involvement in E1 binding to importin . Wild-type
E1 and the four pseudophosphorylation mutants were all expressed in vitro from pRSET. (A) Autoradiograph of the in vitro-translated WT and
mutant E1 proteins bound to importin 1/5 complexes or to GST alone as described in the legend of Fig. 3. Hollow triangles indicate increasing
amounts of importin 5 (0.5, 1.0, and 2.0 g) used in the binding reaction mixtures (for GST, only the results with 2 g are shown). The input
lanes show samples of the original in vitro-translated WT and mutant E1 proteins used for the binding reactions. Two independent experiments
(upper and lower panels) are shown, with the position of the 75-kDa molecular mass marker indicated on the left. (B) Phosphordensitometry
quantification of the bound WT and mutant E1 proteins calculated as described in the legend of Fig. 3C. (C) Tabular presentation of the
quantitative data shown graphically in B.
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serine 385 near the EBNA-1 NLS up-regulates nuclear trans-
port efficiency by increasing the binding affinity of EBNA-1 for
NPI-1 (importin 5), while the phosphorylation of serine 386
and serine 383 down-regulates uptake (22). Numerous other
studies have also shown that phosphorylation near or within
NLS elements can regulate nuclear transport in either a posi-
tive (STAT1 [35] or cytomegalovirus ppUL44 [2]) or negative
(p27Kip1 [54], Swi6p [17], or APC [65]) fashion. Our results
demonstrate that the binding of BPV1 E1 protein to  importins
was significantly decreased when a pseudophosphorylation mu-
tation was introduced at serine 109. Furthermore, the pseu-
dophosphorylation mutant E1 protein failed to enter the nu-
cleus of digitonin-permeabilized HeLa cells in vitro and
showed aberrant nuclear envelope accumulation in transfected
HeLa cells. In contrast, an alanine replacement at serine 109
had no effect on importin binding or E1 nuclear uptake. Why
the pseudophosphorylation mutant exhibits this pattern of nu-
clear envelope association as opposed to simply cytoplasmic
distribution is unclear but likely reflects a more complex inter-
play between E1 and nucleocytoplasmic transport systems than
is present in our reconstituted in vitro system. Nonetheless,
these results imply that E1 phosphorylation at serine 109 in
vivo would negatively regulate E1 nuclear uptake and are con-
sistent with a previous study that examined the replication
function of serine 109 mutants (64). That study found that a
BPV1 viral genome carrying the E1 S109A mutation replicated
to slightly higher levels than the WT genome in an in vivo
transient assay, while an E1 S109E mutant genome replicated
less effectively than the WT. At least a portion of the replica-
tive defect in the S109E mutant might have resulted from the
pseudophosphorylation mutation interfering with importin
-dependent E1 nuclear uptake, resulting in lower intranu-
clear E1 levels than those with WT E1. Conversely, the S109A
mutant that would be constitutively unphosphorylated at this
residue may accumulate to higher intranuclear concentrations,
leading to increased genome replication.
The BPV1 E1 serine 109 is located within a consensus se-
quence for PKC (31) and can be phosphorylated by this en-
zyme in vitro (64). PKC is known to comprise a large family of
at least 12 isozymes that differ in structures, cofactor require-
ments, and functions. Multiple PKC isoforms are expressed in
the epidermis and make different contributions to keratinocyte
proliferation, differentiation, and apoptotic death (12). In the
proliferative basal layer, highly levels of PKCε are detected,
suggesting that PKCε may help drive keratinocyte proliferation
in the basal layer, while PKC, , and 	 are associated with
differentiation (12). The PKC pathway is also an important
regulator of differentiation-dependent HPV31 replication, and
viral genome amplification depends on both PKC and PKC
activity as well as tyrosine kinases (5). Based on these obser-
vations, it is interesting to speculate that diverse PKC isoforms
present in the epithelial layers could have a differential capac-
ity for phosphorylating E1 residue 109 and that this could
provide control of E1 nuclear levels by modulating E1-importin 
interactions and the subsequent E1 uptake, thus coordinating
viral genome replication with a keratinocyte differentiation
stage.
After the completion of most of our study, a new phosphor-
ylation map of the BPV1 E1 protein showing four additional
phosphorylation sites adjacent to or within NLS sequence was
reported (32). Therefore, there are now seven total known
phosphorylation sites in the immediate vicinity of the NLS
sequence (S90, S94, S95, S100, T102, S109, and T126), sug-
gesting that the phosphoregulation of BPV1 E1 nuclear import
may be exceedingly complex. While we have shown that the
pseudophosphorylation of residues T102 and T126 makes at
best a small contribution to E1-importin interactions in the
context of S109D, all three of these residues must now be
reevaluated in conjunction with S90, S94, S95, and S100. Res-
idues S94, S95, and S100 are all predicted to be phosphorylated
by CKII, which is also known to be involved in the regulation
of keratinocyte proliferation (46).
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